FI119722B - Valasikloviiritabletteja, jotka sisältävät kolloidista silikonidioksidia - Google Patents

Valasikloviiritabletteja, jotka sisältävät kolloidista silikonidioksidia Download PDF

Info

Publication number
FI119722B
FI119722B FI973062A FI973062A FI119722B FI 119722 B FI119722 B FI 119722B FI 973062 A FI973062 A FI 973062A FI 973062 A FI973062 A FI 973062A FI 119722 B FI119722 B FI 119722B
Authority
FI
Finland
Prior art keywords
tablet
weight
valaciclovir
granules
lubricant
Prior art date
Application number
FI973062A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI973062A0 (fi
FI973062A (fi
Inventor
Barry Howard Carter
Lloyd Gary Tillman
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10768317&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI119722(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of FI973062A0 publication Critical patent/FI973062A0/fi
Publication of FI973062A publication Critical patent/FI973062A/fi
Application granted granted Critical
Publication of FI119722B publication Critical patent/FI119722B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI973062A 1995-01-20 1997-07-18 Valasikloviiritabletteja, jotka sisältävät kolloidista silikonidioksidia FI119722B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9501127 1995-01-20
GBGB9501127.6A GB9501127D0 (en) 1995-01-20 1995-01-20 Tablet
GB9600111 1996-01-04
PCT/GB1996/000111 WO1996022082A1 (en) 1995-01-20 1996-01-19 Valaciclovir tablets containing colloidal silicon dioxide

Publications (3)

Publication Number Publication Date
FI973062A0 FI973062A0 (fi) 1997-07-18
FI973062A FI973062A (fi) 1997-09-18
FI119722B true FI119722B (fi) 2009-02-27

Family

ID=10768317

Family Applications (1)

Application Number Title Priority Date Filing Date
FI973062A FI119722B (fi) 1995-01-20 1997-07-18 Valasikloviiritabletteja, jotka sisältävät kolloidista silikonidioksidia

Country Status (39)

Country Link
US (1) US5879706A (xx)
EP (1) EP0806943B1 (xx)
JP (1) JP3350055B2 (xx)
KR (1) KR100412298B1 (xx)
CN (2) CN1131026C (xx)
AP (1) AP666A (xx)
AT (1) ATE190483T1 (xx)
AU (1) AU710823B2 (xx)
BG (1) BG63187B1 (xx)
BR (1) BR9606769A (xx)
CA (1) CA2210891C (xx)
CY (1) CY2182B1 (xx)
CZ (1) CZ296514B6 (xx)
DE (1) DE69607146T2 (xx)
DK (1) DK0806943T3 (xx)
EA (1) EA000276B1 (xx)
EE (1) EE03336B1 (xx)
ES (1) ES2145425T3 (xx)
FI (1) FI119722B (xx)
GB (1) GB9501127D0 (xx)
GE (1) GEP20022752B (xx)
GR (1) GR3033677T3 (xx)
HK (1) HK1002851A1 (xx)
HU (1) HU226131B1 (xx)
IL (1) IL116830A (xx)
IN (1) IN181318B (xx)
MY (1) MY126346A (xx)
NO (1) NO311488B1 (xx)
NZ (1) NZ298846A (xx)
OA (1) OA10500A (xx)
PL (1) PL185307B1 (xx)
PT (1) PT806943E (xx)
RO (1) RO118175B1 (xx)
SK (1) SK282030B6 (xx)
TR (1) TR199700657T1 (xx)
UA (1) UA68325C2 (xx)
UY (2) UY25774A1 (xx)
WO (1) WO1996022082A1 (xx)
ZA (1) ZA96448B (xx)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
DK0874631T3 (da) * 1996-01-19 2004-03-22 Glaxo Group Ltd Anvendelse af valaciclovir til fremstilling af et medikament til behandling af genital herpes ved en enkelt daglig anvendelse
AR016827A1 (es) 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
AR017512A1 (es) * 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
PL356899A1 (en) * 1998-12-18 2004-07-12 Abbott Laboratories Controlled release formulation of divalproex sodium
GB0010446D0 (en) 2000-04-28 2000-06-14 Glaxo Wellcome Kk Pharmaceutical formulation
OA12596A (en) * 2001-05-01 2006-06-08 Pfizer Prod Inc Method for manufacturing a low dose pharmaceuticalcomposition.
US7815936B2 (en) * 2001-10-30 2010-10-19 Evonik Degussa Gmbh Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
JP2005511612A (ja) * 2001-11-05 2005-04-28 グラクソ　グループ　リミテッド 塩酸バラシクロビルの無水結晶形
CA2649826A1 (en) * 2001-11-14 2003-05-22 Teva Pharmaceutical Industries Ltd. Synthesis and purification of valacyclovir
GB0203296D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
US20060147519A1 (en) * 2002-06-24 2006-07-06 Ashish Gogia Process for the preparation of robust formulations of valacyclovir hydrochloride tablets
US20050051922A1 (en) * 2002-09-20 2005-03-10 Avinash Nangia Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
US20050059684A1 (en) * 2002-10-16 2005-03-17 Ben-Zion Dolitzky Method for reducing residual alcohols in crystalline valacyclovir hydrochloride
AU2003277433A1 (en) * 2002-10-16 2004-05-04 Teva Pharmaceutical Industries Ltd. Method for reducing residual alcohols in crystalline valacyclovir hydrochloride
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
AU2003232719A1 (en) * 2003-05-30 2005-01-21 Eos Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ticaret A.S. Novel crystalline forms of valacyclovir hydrochloride
EP2014660A3 (en) * 2003-06-02 2009-07-15 Teva Pharmaceutical Industries Ltd Novel crystalline forms of valacyclovir hydrochloride
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
DK1663182T4 (da) 2003-09-12 2020-02-17 Amgen Inc Hurtigt opløsende formulering af cinacalcet HCI
DE10351448A1 (de) * 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
DE60301277T2 (de) * 2003-12-09 2006-03-30 Helm Ag Pharmazeutische zubereitung enthaltend valaciclovir
US7344907B2 (en) * 2004-11-19 2008-03-18 International Business Machines Corporation Apparatus and methods for encapsulating microelectromechanical (MEM) devices on a wafer scale
KR101116747B1 (ko) 2004-12-06 2012-02-22 에스케이케미칼주식회사 안정성이 개선된 말레인산 암로디핀 약제 조성물
JP5304241B2 (ja) 2005-03-07 2013-10-02 バイエル・ヘルスケア・エルエルシー 癌の処置用のオメガ−カルボキシアリール置換ジフェニルウレアを含む医薬組成物
ATE546451T1 (de) * 2005-05-25 2012-03-15 Lilly Co Eli Cyclopropancarbonsäureester von acyclovir
EP1746098A1 (en) * 2005-07-21 2007-01-24 SOLMAG S.p.A. Valacyclovir polymorphs and a process for the preparation thereof
WO2007090595A1 (en) * 2006-02-06 2007-08-16 Fidia Pharmaceutici S.P.A. Solid formulations of valacyclovir hydrochloride
JP2009536165A (ja) * 2006-05-10 2009-10-08 エボニック デグサ ゲーエムベーハー 医薬組成物におけるロール圧縮された熱分解的に製造された二酸化ケイ素の使用
ATE481089T1 (de) * 2006-05-31 2010-10-15 Vertex Pharma Orale formulierungen mit kontrollierter freisetzung eines interleukin-1-beta-converting- enzyme inhibitors
SI2040684T1 (sl) * 2006-07-11 2013-06-28 Lek Pharmaceuticals D.D. Večenotne tablete
US20080167325A1 (en) * 2006-12-27 2008-07-10 Bs Praveen Kumar Valacyclovir compositions
US20090076039A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched valacyclovir
ITRM20080027A1 (it) * 2008-01-18 2009-07-19 Maria Balestrieri Uso di aciclovir per il trattamento delle condilomatosi.
US20100124560A1 (en) * 2008-11-14 2010-05-20 Mcneil Ab Multi portion intra-oral dosage form and use thereof
EP2407166B1 (en) * 2009-03-13 2013-08-21 Toyama Chemical Co., Ltd. Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide
CH703348A1 (de) * 2010-06-29 2011-12-30 Mepha Gmbh Zusammensetzungen mit hohem Wirkstoffanteil an pharmazeutisch aktiven Substanzen.
GB2515486A (en) * 2013-06-24 2014-12-31 Kraft Foods R & D Inc Soluble Beverage Ingredients
KR101497508B1 (ko) * 2013-12-20 2015-03-03 한국유나이티드제약 주식회사 펠라고니움 시도이데스 추출물 및 규산 화합물을 포함하는 고형 제제 및 이의 제조 방법
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
WO2020049536A1 (en) * 2018-09-07 2020-03-12 Jubilant Generics Limited Pharmaceutical compositions of valacyclovir or its pharmaceutically acceptable salts thereof
CN110279667B (zh) * 2019-07-30 2023-02-10 珠海润都制药股份有限公司 一种盐酸伐昔洛韦片及其制备方法
JP2023551524A (ja) * 2020-12-01 2023-12-08 エルジー・ケム・リミテッド １－（３－シアノ－１－イソプロピル－インドール－５－イル）ピラゾール－４－カルボン酸を含む経口用製剤、およびその製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1259924A (en) * 1985-03-25 1989-09-26 Wallace E. Becker Pharmaceutical tableting method
AP160A (en) * 1987-08-15 1991-11-18 The Wellcome Foundation Ltd Therapeutic acyclic nucleosides.
EP0349103B1 (en) * 1988-05-04 1992-11-25 Smith Kline & French Laboratories Limited Chewable tablet
GB2257363B (en) * 1991-01-30 1994-09-28 Wellcome Found Water dispersible tablets containing acyclovir
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
GB9317146D0 (en) * 1993-08-18 1993-10-06 Wellcome Found Therapeutic combinations
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet

Also Published As

Publication number Publication date
HUP9801872A2 (hu) 1999-10-28
AP9701057A0 (en) 1997-10-31
EE03336B1 (et) 2001-02-15
IL116830A (en) 2000-02-29
KR19980701524A (ko) 1998-05-15
EP0806943A1 (en) 1997-11-19
CN1313081C (zh) 2007-05-02
NO973327D0 (no) 1997-07-18
FI973062A0 (fi) 1997-07-18
CZ296514B6 (cs) 2006-03-15
HUP9801872A3 (en) 2001-02-28
NO973327L (no) 1997-09-16
CN1131026C (zh) 2003-12-17
SK282030B6 (sk) 2001-10-08
CN1494898A (zh) 2004-05-12
MX9705459A (es) 1997-10-31
JPH10512564A (ja) 1998-12-02
UY25778A1 (es) 2000-08-21
DE69607146T2 (de) 2000-09-21
KR100412298B1 (ko) 2004-04-21
HU226131B1 (en) 2008-05-28
UY25774A1 (es) 2000-10-31
UA68325C2 (en) 2004-08-16
BR9606769A (pt) 1997-12-30
WO1996022082A1 (en) 1996-07-25
FI973062A (fi) 1997-09-18
CA2210891C (en) 2009-05-19
US5879706A (en) 1999-03-09
IN181318B (xx) 1998-05-09
NO311488B1 (no) 2001-12-03
AP666A (en) 1998-08-24
MY126346A (en) 2006-09-29
GB9501127D0 (en) 1995-03-08
RO118175B1 (ro) 2003-03-28
EP0806943B1 (en) 2000-03-15
ATE190483T1 (de) 2000-04-15
GR3033677T3 (en) 2000-10-31
ES2145425T3 (es) 2000-07-01
PL321361A1 (en) 1997-12-08
DE69607146D1 (de) 2000-04-20
AU4453496A (en) 1996-08-07
OA10500A (en) 2002-04-10
IL116830A0 (en) 1996-05-14
PT806943E (pt) 2000-08-31
HK1002851A1 (en) 1998-09-25
NZ298846A (en) 1998-06-26
CN1179100A (zh) 1998-04-15
ZA96448B (en) 1996-08-07
JP3350055B2 (ja) 2002-11-25
SK96497A3 (en) 1998-01-14
GEP20022752B (en) 2002-08-26
CZ229297A3 (cs) 1998-02-18
BG101831A (en) 1998-04-30
PL185307B1 (pl) 2003-04-30
EA000276B1 (ru) 1999-02-25
EA199700123A1 (ru) 1997-12-30
TR199700657T1 (xx) 1998-02-21
CY2182B1 (en) 2002-08-23
AU710823B2 (en) 1999-09-30
CA2210891A1 (en) 1996-07-25
BG63187B1 (bg) 2001-06-29
DK0806943T3 (da) 2000-07-24

Similar Documents

Publication Publication Date Title
FI119722B (fi) Valasikloviiritabletteja, jotka sisältävät kolloidista silikonidioksidia
JPH0714876B2 (ja) フェノフィブレートを含有する治療用組成物およびその製造方法
KR20120008024A (ko) 니타족사니드의 서방성 제약 제형
KR20160074018A (ko) Ｈｉｖ 인테그라제 억제제의 약동학을 개선하기 위한 방법
AU722304B2 (en) Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by a single daily application
US20190076366A1 (en) Pharmaceutical composition of entecavir and process of manufacturing
KR20160003532A (ko) 테노포비어 디소프록실 인산염과, 비금속염 붕해제 및 비금속염 활택제를 포함하는 약학 조성물
WO2010027340A1 (en) Pharmaceutical compositions composing entakapon, levodopa and karbidoba
CN106955273B (zh) 一种含有钠-葡萄糖协同转运蛋白2抑制剂的药物组合物
RU2479310C2 (ru) Фармацевтическая композиция для лечения артериальной гипертензии и застойной сердечной недостаточности и способ ее получения
KR101811030B1 (ko) 테노포비어 디소프록실 인산염과, 비금속염 붕해제 및 비금속염 활택제를 포함하는 약학 조성물
MXPA97005459A (en) Valaciclovir tablets containing silicon dioxide color
RU2174836C1 (ru) Фармацевтическая композиция, обладающая анальгезирующим действием
AU2011252193A1 (en) Association of xanthine oxidase inhibitors and statins and use thereof
IE20010413A1 (en) Once-a-day pharmaceutical composition containing Brivudine
EA040745B1 (ru) Фармацевтическая композиция, содержащая два различных активных ингредиента, и способ ее получения

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 119722

Country of ref document: FI

MM Patent lapsed